Supplemental material
OncoImmunology
Volume 1, 2012 - Issue 9
Related Research Data
Tumor dormancy in bone.
Source:
Wiley
Role of immature myeloid cells in mechanisms of immune evasion in cancer.
Source:
Springer Science and Business Media LLC
Cancer statistics, 2012
Source:
Wiley
Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis.
Source:
American Society for Clinical Investigation
Roles of the RANKL–RANK axis in antitumour immunity — implications for therapy
Source:
Springer Science and Business Media LLC
Effect of tumor-derived cytokines and growth factors on differentiation and immune suppressive features of myeloid cells in cancer.
Source:
Springer Science and Business Media LLC
Inflammation and breast cancer
Source:
Future Medicine Ltd
Wnt signaling induces gene expression of factors associated with bone destruction in lung and breast cancer
Source:
Springer Science and Business Media LLC
Myeloid-derived suppressor cell heterogeneity and subset definition
Source:
Elsevier BV
Myeloid suppressor cells in cancer: recruitment, phenotype, properties, and mechanisms of immune suppression.
Source:
Elsevier BV
Mechanisms of bone metastases of breast cancer.
Source:
Bioscientifica
Myeloid-derived suppressor cells.
Source:
Springer New York
Myeloid-derived suppressor cells in human cancer.
Source:
Ovid Technologies (Wolters Kluwer Health)
Phase 1B study to improve immune responses in head and neck cancer patients using escalating doses of 25-hydroxyvitamin D3
Source:
Springer Science and Business Media LLC
Retinoid X receptor agonist LG100268 modulates the immune microenvironment in preclinical breast cancer models
Source:
Nature Publishing Group
The efficacy of zoledronic acid in breast cancer adjuvant therapy: A meta-analysis of randomised controlled trials
Source:
Elsevier BV
Metastatic bone disease: clinical features, pathophysiology and treatment strategies.
Source:
Elsevier BV
Linking provided by
